92 participants
Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-08-01
- Start Date:
- 2008-08-31
- Completion:
- 2013-02-28
Conditions
- Lung Cancer
Interventions
- DRUG